Insulin Regulation of Hepatic Glucose Transporter Protein Is Impaired in Chronic Pancreatitis
- 1 June 1994
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 219 (6) , 679-687
- https://doi.org/10.1097/00000658-199406000-00011
Abstract
Objective The effect of chronic pancreatitis and insulin on the expression of the hepatic facilitative glucose transporter protein (GLUT-2) was determined in rats. Summary Background Data Chronic pancreatitis is associated with diabetes mellitus or impaired glucose tolerance. Suppression of hepatic glucose production (HGP) by insulin is impaired, although the mechanism is unknown. Methods Normal rats, rats with chronic pancreatitis induced 12 to 16 weeks earlier by oleic acid injection into the pancreatic ducts, and sham-operated rats were studied. Isolated, single-pass liver perfusion was performed, during which glucagon (1.2 pM) was infused, with or without insulin (0.6 or 1.2 nM). The suppression of HGP production by insulin was compared with changes in GLUT-2 in the membrane fraction of liver biopsies obtained before and after hormone perfusion. Results Glycogen-rich (fed) livers of normal rats (n = 16) demonstrated a dose-dependent suppression of hepatic glucose production by insulin (50 ± 5% HGP induced by glucagon alone during 1.2-nM insulin perfusion) and a dose-dependent decrease in GLUT-2 (30 ± 13% of basal level during 1.2-nM insulin perfusion). Sham-operated rats (n = 6) also showed reductions in HGP (51 ± 4%) and GLUT-2 (14 ± 10%) during 1.2-nM insulin perfusion. In contrast, rats with chronic pancreatitis (n = 6) showed no suppression of HGP during 1.2-nM Insulin perfusion, and an increase in GLUT-2 (+20 ± 6%) after insulin perfusion (p < 0.02 vs. sham). Conclusions Insulin suppresses glucagon-stimulated HGP in normal and sham-operated rats, and this reduction in HGP is associated with a decrease in the membrane-bound quantity of GLUT-2. In chronic pancreatitis, insulin suppression of HGP is absent, and this is accompanied by an increase in GLUT-2 in the hepatocyte membrane. The authors conclude that the insulin-mediated change in the level of hepatocyte GLUT-2 is impaired in chronic pancreatitis, and may contribute to the altered glucose metabolism observed commonly in this disease.Keywords
This publication has 23 references indexed in Scilit:
- Reversal of abnormal glucose metabolism in chronic pancreatitis by administration of pancreatic polypeptideThe American Journal of Surgery, 1986
- In Vivo Hepatic and Peripheral Insulin Resistance in Genetically Obese (fa/fa) Rats*Endocrinology, 1983
- Hepatic and peripheral insulin resistance: A common feature of Type 2 (non-insulin-dependent) and Type 1 (insulin-dependent) diabetes mellitusDiabetologia, 1982
- The effect of cell-free and erythrocyte-containing perfusion in rat liversJournal of Surgical Research, 1980
- Plasma Human Pancreatic Polypeptide Responses to Administered Secretin: Effects of Surgical Vagotomy, Cholinergic Blockade, and Chronic Pancreatitis*Journal of Clinical Endocrinology & Metabolism, 1980
- Evidence that insulin causes translocation of glucose transport activity to the plasma membrane from an intracellular storage site.Proceedings of the National Academy of Sciences, 1980
- Pancreatic polypeptide response in patients with chronic pancreatitisDigestive Diseases and Sciences, 1979
- Kinetics of Insulin Secretion in Chronic Pancreatitis and Mild Maturity Onset Diabetes (Evidence for “Gut Hormone” Action Beyond Glucoreceptor and Cyclic Adenosine Monophosphate Mediated Insulin Release)European Journal of Clinical Investigation, 1976
- Glucagon Secretion in Acute and Chronic PancreatitisAnnals of Internal Medicine, 1975
- Glucagon Responses to Arginine in Chronic Pancreatitis: Possible Pathogenic Significance in DiabetesDiabetes, 1974